Abstract
SAN JUAN, PUERTO RICO-- Complaints about vaccine safety and debate over a mysterious muscle ailment have prompted researchers to take a fresh look at the use of aluminum adjuvants, which are used to cause the immune system to react earlier, more potently, and more persistently to the antigen contained in the vaccine. This month, as some 70 scientists gathered here for 2 days of often vigorous discussion of the findings about the muscle ailment, a larger question hung over the gathering: Will aluminum be the next battleground in the vaccine wars?

This publication has 0 references indexed in Scilit: